Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?
- PMID: 35165995
- DOI: 10.1111/ceo.14033
Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?
Comment on
-
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE.Clin Exp Ophthalmol. 2022 Jan;50(1):23-30. doi: 10.1111/ceo.14024. Epub 2021 Dec 27. Clin Exp Ophthalmol. 2022. PMID: 34741564 Free PMC article. Clinical Trial.
References
REFERENCES
-
- Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of Uveitic macular edema the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019;126(2):283-295.
-
- Chiang B, Jung JH, Prausnitz MR. The suprachoroidal space as a route of administration to the posterior segment of the eye. Adv Drug Deliv Rev. 2018;126:58-66.
-
- Edelhauser H, Patel S, Meschter C, Dean R, Powell K, Verhoeven R. Suprachoroidal Microinjection Delivers Triamcinolone Acetonide to Therapeutically-Relevant Posterior Ocular Structures and Limits Exposure in the Anterior Segment | IOVS | ARVO Journals. In: ARVO Annual Meeting June 2013. IOVS
-
- Yeh S, Khurana RN, Shah M, et al. Efficacy and safety of Suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis phase 3 randomized trial. Ophthalmology. 2020;127(7):948-955.
-
- Fung AT, Tran T, Lim LL, et al. Local delivery of corticosteroids in clinical ophthalmology: a review. Clin Experiment Ophthalmol. 2020;48(3):366-401.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources